TET2 c.3192_3198del ;(p.L1065Dfs*15)

Variant ID: 4-106158289-GTTTTGAC-G

NM_001127208.2(TET2):c.3192_3198del;(p.L1065Dfs*15)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Comprehensive next-generation profiling of clonal hematopoiesis in cancer patients using paired tumor-blood sequencing for guiding personalized therapies.

Clinical And Translational Medicine
Li, Ziyang Z; Huang, Wensou W; Yin, Jiani C JC; Na, Chenglong C; Wu, Xue X; Shao, Yang Y; Ding, Huaxin H; Li, Jinming J
Publication Date: 2020-11

Variant appearance in text: TET2: 3192_3198delTTTGACT; L1065Dfs*15
PubMed Link: 33252848
Variant Present in the following documents:
  • CTM2-10-e222-s003.xlsx, sheet 1
View BVdb publication page



Short-Term Responders of Non-Small Cell Lung Cancer Patients to EGFR Tyrosine Kinase Inhibitors Display High Prevalence of TP53 Mutations and Primary Resistance Mechanisms.

Translational Oncology
Xu, Yanjun Y; Tong, Xiaoling X; Yan, Junrong J; Wu, Xue X; Shao, Yang W YW; Fan, Yun Y
Publication Date: 2018-12

Variant appearance in text: TET2: 3191_3197delTTTTGAC
PubMed Link: 30196239
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page